SCHEMBL1010438

SCHEMBL1010438

Cc1ccnc(Oc2cccc(CO)c2)c1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 8/20 0.44
PPARG P37231 1/20 0.43
NR1H2 P55055 2/20 0.43
NR1H3 Q13133 2/20 0.43
LOX P28300 6/20 0.42
F10 P00742 1/20 0.42
KDR P35968 1/20 0.41
MAP2K4 P45985 1/20 0.40
GPBAR1 Q8TDU6 1/20 0.40
CYSLTR1 Q9Y271 1/20 0.40
RET P07949 1/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
DRD1 P21728 1/20 0.39
FFAR1 O14842 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3288094 0.85 LOXL2 (0.61) LOXL2LOX
SCHEMBL13452508 0.85 LOXL2 (0.47) LOXL2NR1H2NR1H3LOXF10
SCHEMBL1011166 0.85 LOXL2 (0.43) LOXL2PPARGLOXRETDRD1
SCHEMBL27209663 0.82 LOXL2 (0.44) LOXL2NR1H2NR1H3LOXF10
SCHEMBL21328434 0.80 PPARG (0.46) LOXL2PPARGLOXF10KDR
SCHEMBL1747080 0.80 MGLL (0.47) LOXL2LOXGPBAR1CYSLTR1TSHR
SCHEMBL1011129 0.79 NR1H2 (0.46) PPARGNR1H2NR1H3F10KDR
SCHEMBL1747441 0.79 ALDH1A1 (0.53) NR1H2NR1H3F10TSHRSMN1; SMN2
SCHEMBL30979256 0.79 ALDH1A1 (0.53) NR1H2NR1H3F10TSHRSMN1; SMN2
SCHEMBL3158059 0.79 LOXL2 (0.44) LOXL2LOXF10GPBAR1CYSLTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044052-B2 Inhibitors of fatty acid amide hydrolase; N-pyridin-3-yl-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide; elevate brain anandamide levels; pain, urinary incontinence, cognitive disorders, anxiety, depression, sleeping, eating, movement disorders, glaucoma, psoriasis PFIZER INC. (US) 2011-10-25 US disclosed
EP-2076508-B1 BIARYL ETHER UREA COMPOUNDS PFIZER PROD INC (US) 2011-01-05 EP disclosed